Bibliography
- Costantino L, Barlocco D. Ghrelin receptor modulators and their therapeutic potential. Future Med Chem 2009;1:157-77
- Ozawa A, Speaker RB, Lindberg I. Enzymatic characterization of a human acyltransferase activity. PLoS One 2009;4:e5426
- Dale JW, Hollingworth GJ, McKenna JM. Developments and advances in gastrointestinal prokinetic agents. Ann Rep Med Chem 2011;46:135-54
- Sallam HS, Chen JDZ. The prokinetic face of ghrelin. Int J Pept 2010; article ID 493614
- Hoveyda HR, Marsault E, Gagnon R, Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): development of Ulimorelin (TZP-101) from hit to clinic. J Med Chem 2011;54:8305-20
- Hanrahan P, Bell J, Bottomley G, Substituted azaquinazolinones as modulators of GHSR-1a for the treatment of type II diabetes and obesity. Bioorg Med Chem Lett 2012;22:2271-8
- Mihalic JT, Kim YJ, Lizarzaburu M, Discovery of a new class of ghrelin receptor antagonists. Bioorg Med Chem Lett 2012;22:2046-51
- Costantini VJA, Vicentini E, Sabbatini FM, GSK 1614343, a novel ghrelin receptor antagonist, produces an unexpected increase of food intake and body weight in rodents and dogs. Neuroendocrinology 2011;94:158-68
- Sabbatini FM, Melotto S, Bernasconi G, Azabicyclo[3.1.0]hexane-1-carbohydrazides as potent and selective GHSR1a ligand presenting a specific in vivo behavior. ChemMedChem 2011;6:1981-5
- Moulin A, Demange L, Ryan J, New trisubstituted 1,2,4-triazole derivatives as potent ghrelin receptor antagonists. 3. Synthesis and pharmacological in vitro and in vivo evaluations. J Med Chem 2008;51:689-93
- Moulin A, Demange L, Berge G, Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. synthesis and pharmacological in vitro and in vivo evaluations. J Med Chem 2007;50:5790-806
- Barnett BP, Hwang Y, Taylor MS, Glucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor. Science 2010;330:1689-92
- Growth hormone secretagogue receptor antagonists. WO2011159917A2; 2011
- Dodge JA, Heiman ML. Ghrelin receptor modulators. Ann Rep Med Chem 2003;38:81-8
- Costantino L. Methods for synthesis and uses of inhibitors of ghrelin O-acyltransferase as porential therapeutic agents for obesity and diabetes. Exp Opin Ther Patents 2010;20:1603-7
- Pralmorelin. Drugs Future 2005;30:124-7
- Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LN. Drugs R D 2004;5:236-9